• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.emendobio.com/

EmendoBio is involved in developing CRISPR-based gene editing technologies to address complex genetic diseases, focusing on optimizing nucleases and guide-RNAs for effective disease-specific solutions.